韩国联邦贸易委员会因向其附属公司提供不公平的利益而罚款309,900美元. South Korea's FTC fined Celltrion $309,900 for favoring its affiliate with unfair benefits.

韩国联邦贸易委员会处罚生物制药公司Celltrion 309 900美元,罪名是不公平的商业做法,包括偏袒其附属公司Celltrion Healthcare, 免收收费和免费商标,提供价值873 000美元的不正当好处。 South Korea's FTC fined biopharmaceutical firm Celltrion $309,900 for unfair business practices, including favoring its affiliate, Celltrion Healthcare, with waived fees and free trademarks, which provided undue benefits valued at $873,000. 公平贸易委员会决定不将主席交由检察官处理,原因是其参与的好处数额和不确定性。 The FTC decided not to refer the chairman to prosecutors due to the benefit amount and uncertainty over his involvement. 尽管季度销售额很高,但elltrion的第三季度净收入下跌了62%。 Despite high quarterly sales, Celltrion's third-quarter net income dropped 62%.